EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metal‐Organic Framework‐Based Nanomedicines for Ferroptotic Cancer Therapy

Yue Song, Xinran Xu, Zheng Wang, Yanjun Zhao iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202303533 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Yue Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, Tianjin University, Tianjin, 300072…. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Ferroptosis, Nanomedicine, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As an iron‐dependent, non‐apoptosis, regulated cell death (RCD) modality, ferroptosis has gained growing attention for cancer therapy. With the development of nanomaterials in the biomedical field, ferroptotic cancer nanomedicine is extensively investigated. Amongst various nanomaterials, metal‐organic frameworks (MOFs) are hybridized porous materials consisting of metal ions or clusters bridged by organic linkers. The superior properties of MOFs, such as high porosity and cargo loading, ease of surface modification, and good biocompatibility, make them appealing in inducing or sensitizing ferroptotic cell death. There are remarkable achievements in the field of MOF‐based ferroptosis cancer therapy. However, this topic is not reviewed. This review will introduce the fundamentals of MOF and ferroptosis machinery, summarize the recent progress of MOF‐based ferroptotic anticancer drug delivery, discuss the benefits and problems of MOFs as vehicles and sensitizers for cancer ferroptosis, and provide the perspective on future research direction on this promising field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksFerroptosisNanomedicineNeoplasmsHumansAntineoplastic AgentsAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

cancer therapydrug deliveryferroptosismetal‐organic frameworknanomedicine

Substanzen

Metal-Organic FrameworksAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, Tianjin University, Tianjin, 300072, China.
  • Department of Obstetrics, Tianjin Central Hospital of Obstetrics and Gynecology, Nankai University Affiliated Maternity Hospital, Tianjin, 300100, China.

ORCID-Profile: Yanjun Zhao

Förderung

  • National Natural Science Foundation of China
  • Tianjin Municipal Health Commission

Zitieren

APA

Song, Y., Xu, X., Wang, Z., & Zhao, Y. (2024). Metal‐Organic Framework‐Based Nanomedicines for Ferroptotic Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303533

Vancouver

Song Y, Xu X, Wang Z, Zhao Y. Metal‐Organic Framework‐Based Nanomedicines for Ferroptotic Cancer Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303533

BibTeX
@article{Song2024,
  author = {Song, Yue and Xu, Xinran and Wang, Zheng and Zhao, Yanjun},
  title = {Metal‐Organic Framework‐Based Nanomedicines for Ferroptotic Cancer Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202303533}
}
Kostenlos starten →